Surgical Site Infection (SSI)NCT07580274
Effect of Early vs Late Water Exposure After Cutaneous Surgery
A study testing Care as usual in people with Surgical Site Infection (SSI), run by Pak Emirates Military Hospital.
Trial summary
This randomized controlled trial aims to compare the effect of early versus delayed water exposure after cutaneous surgeries on the incidence of surgical site infections. Patients undergoing elective cutaneous surgical procedures will be randomly assigned to either early postoperative water exposure within 48 hours or… Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Surgical Site Infection (SSI)
- What is being tested?
- Care as usual
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 82 participants
- Where
- No sites listed yet
- Study dates
- 1 Jun 2026to 1 Dec 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- Patients undergoing elective surgical procedures, such as excision of benign or malignant skin lesions, skin grafts, and skin biopsies.
Who cannot join
- 1.Patients on anti-coagulants.
- 2.Compromised immune systems e.g. pregnancy, diabetes, immunosuppressive therapies.
- 3.Wounds that are located in areas with significant movements (e.g. joints) or that are highly prone to external contaminants (e.g. mucosal surfaces) which might bias result.
About this study
Official title: Effect of Early vs Late Exposure of Water Post-cutaneous Surgeries : A Randomized Controlled Trial
This randomized controlled trial aims to compare the effect of early versus delayed water exposure after cutaneous surgeries on the incidence of surgical site infections. Patients undergoing elective cutaneous surgical procedures will be randomly assigned to either early postoperative water exposure within 48 hours or delayed exposure after 7 days. Wound outcomes will be assessed using the Southampton Wound Grading System during follow-up visits. The study seeks to determine whether early water exposure is safe and whether it influences postoperative wound healing and infection rates.
- Conditions
- Surgical Site Infection (SSI)
- Being tested
- Care as usual
- Keywords
- Cutaneous surgery, Surgical wound infection, Early water exposure, Post operative wound care
- Medical subject headings
- Surgical Wound Infection
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Care as usualBehavioural
Also called Early Post operative Wound care
Participants will be allowed early exposure of the postoperative wound to water following cutaneous surgery according to the study protocol.
Care as usualBehavioural
Also called Standard Post operative wound care
Participants will follow conventional postoperative wound care instructions with delayed exposure of the surgical wound to water.
| Study group | Role | What they receive |
|---|---|---|
| Early Water Exposure Group | Experimental | Participants will be allowed early postoperative wound exposure to water after cutaneous surgery and will be monitored for wound infection and healing outcomes. Receives: Behavioral: Care as usual |
| Standard Wound Care Group | Active comparator | Participants will follow conventional postoperative wound care instructions with delayed water exposure after cutaneous surgery. Receives: Behavioral: Care as usual |
What is being measured
The primary outcome is the main question the study is designed to answer.
Postoperative Surgical Site Infection
Assessment of the frequency of surgical site infection following cutaneous surgery in participants receiving early versus delayed postoperative water exposure.
Measured: 14 days postoperative
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 May 2026
- Study start1 Jun 2026 (estimated)
- Primary completion1 Dec 2026 (estimated)
- Study completion1 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Surgical Site Infection (SSI)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 82 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Pak Emirates Military Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Saba Khan, Pak Emirates Military Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07580274
- Sponsor's protocol ID
- PEMH-DERM-2026-01
- Status last verified
- May 2026
- First submitted
- 6 May 2026
- Last updated
- 12 May 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 12 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Early vs Late Exposure of Water Post-cutaneous Surgeries : A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07580274
- Acronym / sponsor ID
- PEMH-DERM-2026-01
- Conditions
- Surgical Site Infection (SSI)
- Keywords
- Cutaneous surgery, Surgical wound infection, Early water exposure, Post operative wound care
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 82 participants (estimated)
- Lead sponsor
- Pak Emirates Military HospitalUniversity, hospital or other
- Study start
- 1 Jun 2026 (estimated)
- Primary completion
- 1 Dec 2026 (estimated)
- Study completion
- 1 Dec 2026 (estimated)
- First posted
- 12 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This randomized controlled trial aims to compare the effect of early versus delayed water exposure after cutaneous surgeries on the incidence of surgical site infections. Patients undergoing elective cutaneous surgical procedures will be randomly assigned to either early postoperative water exposure within 48 hours or delayed exposure after 7 days. Wound outcomes will be assessed using the Southampton Wound Grading System during follow-up visits. The study seeks to determine whether early water exposure is safe and whether it influences postoperative wound healing and infection rates.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Early Water Exposure Group | Experimental | Behavioral: Care as usualParticipants will be allowed early postoperative wound exposure to water after cutaneous surgery and will be monitored for wound infection and healing outcomes. |
| Standard Wound Care Group | Active comparator | Behavioral: Care as usualParticipants will follow conventional postoperative wound care instructions with delayed water exposure after cutaneous surgery. |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (1 listed)
- Patients undergoing elective surgical procedures, such as excision of benign or malignant skin lesions, skin grafts, and skin biopsies.
Key exclusion criteria (3 listed)
- 1.Patients on anti-coagulants.
- 2.Compromised immune systems e.g. pregnancy, diabetes, immunosuppressive therapies.
- 3.Wounds that are located in areas with significant movements (e.g. joints) or that are highly prone to external contaminants (e.g. mucosal surfaces) which might bias result.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Care as usualAlso: Early Post operative Wound careParticipants will be allowed early exposure of the postoperative wound to water following cutaneous surgery according to the study protocol. | Behavioural | Early Water Exposure Group |
| Care as usualAlso: Standard Post operative wound careParticipants will follow conventional postoperative wound care instructions with delayed exposure of the surgical wound to water. | Behavioural | Standard Wound Care Group |
Primary outcome
Postoperative Surgical Site Infection
Time frame: 14 days postoperative
Assessment of the frequency of surgical site infection following cutaneous surgery in participants receiving early versus delayed postoperative water exposure.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 May 2026.
Related trials for Surgical Site Infection (SSI)
Not yet recruitingObservational study
Pilot Study on the Effectiveness and Safety of OPTILENE® SILVER MESH ELASTIC in Prevention of Surgical Site Infection (SSI) and Incisional Hernia (IH)
Abdominal Aortic Aneurysm, Morbid Obesity
Not yet recruitingPhase 3
Efficacy of Integrating Next Generation Sequencing for Treatment of Surgical Site Infection After Fracture Fixation:
Next Generation Sequencing (NGS), Surgical Site Infection (SSI)
Not yet recruitingPhase 3
Evaluation of the Effect of Antibiotic Prophylaxis During Lumpectomy for Breast Cancer: Prospective Randomised Double-blind Noninferiority Study of Placebo vs Cefazolin
Breast Cancer, Breast Surgery
Recruiting
Skin Staples vs Polypropylene in Elective Laparotomy
Surgical Site Infection
Not yet recruitingObservational study
Gene Expression Analysis of Biofilm Formation and Antimicrobial Resistance in Clinical Methicillin-Resistant Staphylococcus Aureus
Staphylococcal Aureus Infection, Surgical Site Infection (SSI)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
A study testing Care as usual in people with Surgical Site Infection (SSI), run by Pak Emirates Military Hospital.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 12 May 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Postoperative Surgical Site Infection (time frame: 14 days postoperative). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 May 2026.